HOME >> BIOLOGY >> NEWS
Treating precancerous breast cells may prevent onset of cancer

Boston, MA (October 17, 2002) Treating precancerous breast cells with chemopreventive agents, such as tamoxifen, limits the development of breast cancer in genetically predisposed women, according to a study presented at the American Association for Cancer Research's (AACR) annual Frontiers in Cancer Prevention meeting. Precancerous breast cells may also provide an effective mechanism for screening new and current chemopreventive agents.

The study used precancerous breast cells from patients with Li-Fraumeni syndrome (LFS), a hereditary cancer predisposition syndrome associated with a number of childhood cancers and the early onset of breast cancer. Unlike most human cancer cells, LFS cells become cancerous at more measurable rates in vitro (a closed environment, e.g. test tube), and are therefore easier to monitor. Individuals with LFS are at increased risk for developing multiple primary cancers, including soft-tissue sarcoma, breast cancer, leukemia, osteosarcoma, melanoma and colorectal cancers.

"To effectively treat or prevent cancer, it is important to understand the nature of how cells progress into the disease," explained Brittney-Shea Herbert, Ph.D., cell biologist at The University of Texas Southwestern Medical Center, Dallas, and lead investigator of the study. "Results from human clinical trials take many years to generate so it is imperative that alternate testing forms, such as precancerous cells, be used to determine the effectiveness of precancerous agents."

Treatment of precancerous LFS breast cells with some but not all chemopreventive agents decreased the development of cancer in vitro. The chemopreventive agents used in this study did not negatively affect normal cell growth, nor result in notable side effects from the treatment. Tamoxifen had the strongest effect in preventing the frequency of cell immortalization, at nontoxic levels.

Precancerous cells were treated with tolerable levels of tamoxifen,
'"/>

Contact: Aimee Frank
AMF@spectrumscience.com
202-369-1654
American Association for Cancer Research
17-Oct-2002


Page: 1 2

Related biology news :

1. Treating strokes with blood cord cells holds promise, Saint Louis University rat study shows
2. Treating bacterial infections can help asthmatics
3. Treating metastatic disease with a modified herpesvirus
4. Treating acne with antibiotics leads to resistance
5. Study Provides Guidance For Treating Patients With Brain Aneurysms
6. Relapses Prevented In Mouse Model Of Multiple Sclerosis: Research Aimed At Treating Relapses In Human MS
7. Mechanism Of Protein Folding Unraveled, With Eventual Implications For Treating Diseases Caused By Folding Errors
8. Gene Therapy In A Liquid May Lead To Quicker, Easier Methods For Treating Disease
9. New Class Of Protease Inhibitors May Be Effective In Treating One Of Latin Americas Most Devastating Diseases
10. Study Finds Shorter Period Of Drug Therapy Is Effective In Treating Stomach Ulcers Caused By H. Pylori
11. Treating Anemia Reduces Risk Of Death For People With HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/22/2019)... , ... February 20, 2019 , ... ... announced plans today to expand the company’s footprint in Frederick, MD after a ... have used RoosterBio’s adult human mesenchymal stem/stromal cell (hMSCs) products to streamline their ...
(Date:2/22/2019)... ... , ... Clean label food is not just another passing trend in the ... is quite common to spot consumers running their index finger across the back of ... label scrutiny. , More than ever, meat and poultry producers are working diligently ...
(Date:2/22/2019)... ... February 21, 2019 , ... ... implanted SpineFrontier’s SacroFuse system in conjunction with NanoFUSE’s Orthobiologic ... case represents the first time that either SacroFuse or NanoFUSE have been used ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... ... This free webinar will review strategies for data management in modular and adaptive ... build times by up to 30 percent, reducing cost while increasing quality, achieving clinical site ... need to migrate data – reducing risk and impact on trial success, trial teams, and ...
(Date:3/14/2019)... ... March 14, 2019 , ... EyeCRO ... Oklahoma City, OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma Medical ... as the fifth institution in Oklahoma to receive this prestigious endorsement. The ...
(Date:3/14/2019)... ... March 13, 2019 , ... The International Society for ... taking place in Brussels, Belgium on 25–26 September 2019. This event is a ... innovative approaches. , “Biopharmaceuticals have become a main pillar in the pharmaceutical ...
(Date:3/11/2019)... ... March 11, 2019 , ... USDM Life Sciences and Generis ... with built in GxP compliance for the life sciences industry. USDM Cloud Assurance ... continuous compliance for Generis’ flagship product, CARA. , Presentation One:, ...
Breaking Biology Technology:
Cached News: